All-in-one Hangzhou Protocol: killing four birds with one stone

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis2024 · 126 citations
2. 2Interim Phase 1 study of sequential CD7 CAR T-cell therapy and haploidentical HSCT without GVHD prophylaxis in patients with Relapsed/Refractory CD7-positive hematologic malignancies2025 · 1 citations
3. 3CD7 CAR-T therapy: current developments, improvements, and dilemmas2025 · 5 citations
4. 4CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: Single-arm, open-label, phase I study2025
5. 5Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation2024 · 4 citations